Best Life Sciences Platforms and Tools Companies in Denmark
The 94 best Life Sciences Platforms and Tools companies in Denmark in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Evosep.
Denmark's Life Sciences Platforms and Tools sector earns its place on any serious investor shortlist, and this directory ranks the best companies in Denmark by disclosed equity funding and recent funding momentum across 94 tracked firms. Total disclosed funding sits at $336M. No unicorns yet, but the pipeline is real.
The [global market was valued at roughly $89.4B in 2020 and is forecast to reach $183.8B by 2027 at a 10.8% CAGR](https://precedenceresearch.com), driven by advances in mass spectrometry resolution and quantitative accuracy. Evosep leads our directory at $49M raised, with Biosyntia ($23M) and Ossiform ($21M) close behind. So what does that funding concentration tell you? It signals that instrumentation and bioprocessing are pulling capital while broader coverage stays flat. Hot themes right now are diagnostic biotechnology and drug repurposing AI, and as shown in 2010 research on genomic tooling, platform-layer investments tend to compound returns across multiple downstream applications. Regulatory challenges remain a structural friction point for smaller filers, which is worth factoring into any due diligence here.
- ResearchAndMarkets.com
- Precedence Research
Our analysis of 50 Life Sciences Platforms and Tools companies
$4.8b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Platforms and Tools companies in Denmark
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Evosep Developer of solutions for clinical proteomics | $49M | 41 mo ago | 20 | Ole Vorm Founder & Director | Cart FunctionalityWooCommerceWordPress+40 | — | 2 job openings |
| 2 | Upfront Chromatography Provides chromatography technology for protein separation processes | $32M | 221 mo ago | 5 | — | — | 118 patents Large‑scale chromatography media and processes for protein and oligosaccharide purification | — |
| 3 | BioImage Developer of bioassays for biopharmaceutical companies and research institutions | $30M | 292 mo ago | 42 | Fuhui Long Co-Founder | — | 9 patents Patents concentrated in chemistry & materials | — |
| 4 | Unibio Pioneering planet-friendly protein production through advanced fermentation for animal and human nutrition | $30M | 38 mo ago | 59 59 → 142 (+141%) · sector median +54% | — | WebflowVimeoAmazon Web Services+18 | 109 patents Optimizing microbial fermentation for single‑cell protein and biomass production | — |
| 5 | Biosyntia Developing biocatalysts using synthetic biology and metabolic engineering technology | $23M | 47 mo ago | 19 19 → 22 (+16%) · sector median +54% | Hans Genee Co-Founder and CSO | WebflowTypekitGoogle Font API+9 | — | — |
| 6 | Exiqon Develops LNA-based tools for diagnostics and research | $23M | 127 mo ago | 65 | — | — | 187 patents MicroRNA-based diagnostics and quantification for prostate cancer detection and prognosis | — |
| 7 | Ossiform Developer of 3D printed resorbable bone implants | $21M | 44 mo ago | 11 11 → 16 (+45%) · sector median +54% | Morten O Andersen Co-Founder | — | — | — |
| 8 | Rivelin Drug delivery platform to deliver a pharmaceutical drug uni-directional to a mucosal surface | $20M | 109 mo ago | 6 | — | — | — | — |
| 9 | Immudex Provider of immune monitoring reagents and services for research and clinical use | $19M | 16 mo ago | 39 39 → 46 (+18%) · sector median +54% | Patrik Dahlen Chief Executive Officer | Cart FunctionalitySalesforceBootstrap+21 | — | — |
| 10 | Flow Robotics Provider of an AI-based laboratory automation robot system for liquid handling | $17M | 48 mo ago | 28 | Andres Faina Co-Founder | WordPressMySQLPHP+20 | 6 patents Automated laboratory tube handling and scanning robotics for high-throughput testing. | — |
| 11 | Borean Pharma Protein technology platform for the development of human protein products | $17M | 254 mo ago | — | Johanna Holldack Ex - CEO | — | 10 patents Engineered protein biologics: cytokine/TNF antagonists, HIV fusion inhibitors, protease‑cleavable therapeutics | — |
| 12 | Samplix ApS Provider of microfluidics-based technology for the encapsulation of microbial and mammalian cells | $13M | 38 mo ago | 26 26 → 31 (+19%) · sector median +54% | Marie Mikkelsen Co-founder & CTO | SalesforceWindows ServerMicrosoft ASP.NET+12 | 65 patents Fluorinated surfactant microfluidics for droplet generation, sorting, and DNA enrichment | — |
| 13 | Nuevolution Developer of drug treatments for oncology and chronic inflammatory diseases | $12M | 168 mo ago | 40 | — | — | 335 patents Design of heterocyclic small‑molecule modulators for nuclear receptors and bromodomain targets | — |
| 14 | Clinical Microbiomics Provider of meta-genomics platform and services | $10M | 44 mo ago | 26 | — | WordPressMySQLPHP+19 | — | 1 job opening |
| 15 | Inniti Developer of an IoT device for laboratory management | $4M | 61 mo ago | 6 | Anders Rasmussen Co-Founder | — | — | — |
| 16 | GlycoSpot Provider of solutions for high throughput enzyme screening | $4M | 48 mo ago | 7 | Mads Hartvig Clausen Founder | — | — | 1 partnership |
| 17 | Twelve Bio Developer of CRISPER technology based diagnostics and therapeutics | $3M | 69 mo ago | 10 | Stefano Stella Co-Founder & CEO | — | — | — |
| 18 | PixieGene Provider of a genetically modified porcine models for research for degenerative aging disorders | $2M | 111 mo ago | — | Kaj Vestergaard CEO | — | — | — |
| 19 | Immunitrack Provider of a broad portfolio of reagents and immunogenicity assays | $1M | 67 mo ago | 12 | Sune Justesen Co-Founder | — | — | — |
| 20 | Fidabio Provider of tech-enabled protein and nano-particle analysis services | $1M | 66 mo ago | 17 17 → 39 (+129%) · sector median +54% | — | Webflowstyled-componentsReact+27 | — | 1 launch |
| 21 | EntomoPharm Develops insect based screening models | $1M | 180 mo ago | — | Peter Aadal Nielsen Ex-CEO and Founder | — | 2 patents Insect-derived ex vivo blood‑brain barrier assay for nanoparticle penetration testing | — |
| 22 | Anapa Biotech Molecular tools to enhance the nucleic acids in PCR-based assays | $1M | 232 mo ago | 1 | Soren Echwald Owner & CEO | — | 7 patents Dual-quencher multiplex fluorescence assays for sensitive nucleic acid detection | — |
| 23 | Biomatics Technology Developer of an instrument system for automated sampling and real-time monitoring | $961K | 71 mo ago | 1 | Jesper Bryde-Jacobsen Managing Director | — | — | — |
| 24 | Alphalyse Provider of protein analysis services | $939K | 104 mo ago | 23 23 → 47 (+104%) · sector median +54% | Thomas Kofoed CEO and founder | WordPressMySQLSalesforce+15 | — | 1 job opening |
| 25 | Fluisense Provider of a blood sampling and storage device | $333K | 66 mo ago | 8 | Malene Schroder Co-Founder & CEO | — | — | — |
| 26 | OptoRobotix Develoeper of flow cytometers for cell sorting | $328K | 129 mo ago | 2 | — | — | — | — |
| 27 | COBO Technologies Manufacturer of products for genome editing | $270K | 85 mo ago | 2 | Jens Ole Bock Co-Founder & CEO | — | — | — |
| 28 | Biogenity Contract research organization specializing in omics research and discovery | $203K | 77 mo ago | — | Louis Loeb Co-Founder & Cco | BootstrapApache HTTP ServerCloudflare+9 | — | 3 job openings |
| 29 | atSpiro Developer of an automated single-use bioreactor for fermentation and cell cultivation of microbial cells | $173K | 66 mo ago | 4 | Toke Faurby Co-Founder & CEO | — | — | — |
| 30 | Tagarno Developer and manufacturer of digital microscopes and assorted accessories | $108K | 61 mo ago | 16 16 → 26 (+62%) · sector median +54% | — | WordPressMySQLPHP+35 | — | 3 launchs |
Top 12 Life Sciences Platforms and Tools companies in Denmark
#1
Series A · Copenhagen, Capital Region of Denmark · founded 2009 · 39 employees$19Mraised▾
Provider of immune monitoring reagents and services for research and clinical use. It offers a portfolio of products, including dextramer reagents for flow cytometry and other applications, Klickmer reagents, and custom solutions. The products are used to detect and characterize antigen specific immune cells, supporting research in areas such as vaccine development, cell therapy, and infectious disease. It also provides services such as custom allele production and proficiency testing. Its offerings enable researchers and clinicians to gain a deeper understanding of the immune response in various contexts.It provides a range of products and services such as Dextramer and dcode MHC multimers for detailed immune profiling, clinical grade reagents, monomers and U- Load reagents, techincal and scientfic support, and more.
- Feb 2025Series A$290.6K
- Feb 2024Series A$305.1K
- Mar 2023Series A$245.5K
- Apr 2022Series A$249K
#2
Acquired · Odense, Region of Southern Denmark · founded 2016 · 20 employees$48.8Mraised▾
Developer of solutions for clinical proteomics. The product portfolio of the company includes Evosep One an integrated separation and purification system for preparing chromatography samples and Evotips a miniature, disposable trap-columns. Samples are loaded onto Evotips for desalting and cleaning prior to analysis on the Evosep One system. The system has multiple applications such as diagnostics, biomarker discovery in plants and humans, along with several other applications.
- Jan 2023Series A$42.6M
- Dec 2018Seed$1.5M
- Jan 2018Seed$1.7M
- May 2017Seed$1.2M
#3
Series D · Odense, Region of Southern Denmark · founded 2001 · 59 employees$30Mraised▾
Pioneering planet-friendly protein production through advanced fermentation for animal and human nutrition. The company is dedicated to creating a sustainable future by developing scalable, drop-in protein solutions. They utilize a unique gas-liquid fermentation technology to transform carbon-rich gases into a boundless source of protein, addressing the growing global demand while minimizing environmental impact. Their innovative approach enhances food security, combats deforestation, and reduces overfishing. The company produces microbial protein suitable for aquaculture, livestock, pet food, and human nutrition. They are committed to transforming the protein industry by offering planet-friendly alternatives and fostering collaborations to prioritize food security and sustainability. The company focuses on research and development, technology licensing, and partnerships to expand the reach of their sustainable protein solutions.
- Mar 2023Series D—
- Jun 2021Series D$15M
- Aug 2019Series D$15M
- Nov 2018Grant (prize money)$2.7M
#4
Series A · Birkerod, Capital Region of Denmark · founded 2013 · 26 employees$12.8Mraised▾
Provider of microfluidics-based technology for the encapsulation of microbial and mammalian cells. The company has developed a microfluidics instrument called Xdrop that encapsulates the target living cells, DNA fragments, or organelles together with the assay chemistry is highly stable double-emulsion droplets. It has applications for cell reaction screening and verification of gene edits.
- Mar 2023Grant (prize money)—
- Apr 2021Grant (prize money)$60.6K
- Dec 2020Series A$6.6M
- May 2019Grant (prize money)$2.1M
#5
Series B · Copenhagen, Capital Region of Denmark · founded 2012 · 19 employees$23.4Mraised▾
Biosyntia uses synthetic biology and metabolic engineering to produce biocatalysts with its patent-pending high-throughput screening technology. Their biocatalysis process enables complex chemical production by fermentation and also reduce both production costs and environmental impact as compared to another chemical synthesis.
- Jul 2022Series B$15.5M
- Apr 2018Series A$4.9M
- Jan 2018Grant (prize money)$348.4K
- Jan 2017Grant (prize money)$584.5K
#6
Series B · Odense, Region of Southern Denmark · founded 2017 · 11 employees$20.6Mraised▾
Developer of 3D printed resorbable bone implants. The company has patented 3D printing technology to produce ß-tricalcium phosphate-based P3D Scaffold to create more relevant tissue- and disease models.
- Oct 2022Series B$6.8M
- Nov 2020Series A$3.5M
- May 2020Series A$10.2M
- Feb 2020Grant (prize money)$15K
#7
Series A · Copenhagen, Capital Region of Denmark · founded 2015 · 28 employees$17.1Mraised▾
Provider of an AI-based laboratory automation robot system for liquid handling. It enables users to assist, automate, handle, analyze, process, manage, and control laboratory activities. Its product portfolio includes liquid handling robots, scanners, plates, shakers, and accessories. Its offering includes lab automation tools, research tools, and material handling tools.
- May 2022Series A$12.6M
- May 2021Seed$2.5M
- Aug 2020Seed$56.9K
- Jun 2019Seed$814.6K
#8
Series A · Horsholm, Capital Region of Denmark · founded 2016 · 26 employees$9.7Mraised▾
Provider of meta-genomics platform and services. The company offers a comprehensive portfolio of services for microbiome studies such as Kits supply, Sample storage, metagenomics, transcriptomics, specialized microbiome characterization (e.g. real-time qPCR and strain type analysis), bioinformatics, and statistical analysis. It also provides customized sequencing solutions based on a particular project.
- Oct 2022Series A$9.7M
- Jan 2021Grant (prize money)$364.9K
- Sep 2020Grant (prize money)$354.7K
- Sep 2018Grant (prize money)$345.7K
#9
Acquired · Vedbaek, Capital Region of Denmark · founded 1995 · 65 employees$22.9Mraised▾
Exiqon develops LNA-based (Locked Nucleic Acid) tools for diagnostics and research. It has two major business units: Life Science and Diagnostics. Exiqon Life Sciences develops LNA-based kits for research use. Exiqon Diagnostics uses LNA-based tools for biomarker detection and the development of novel molecular diagnostic tests. In April 2016, Qiagen acquired Exiqon for $103M.
- Nov 2015Conventional Debt$40M
- Jun 2005Series B$19.7M
- Dec 2003Series A$3.2M
#10
Series B · Copenhagen, Capital Region of Denmark · founded 1992 · 5 employees$32.3Mraised▾
Upfront Chromatography is a biotech company that develops and manufactures products and technologies for extraction and recovery of biotherapeutics, functional biomolecules, macromolecular complexes, and even living cells. The company offers its patented technology Rhobust EBA process for high density chromatography adsorbent beads, among others.
#11
Seed · Frederiksberg, Capital Region of Denmark · founded 2014 · 7 employees$3.6Mraised▾
Provider of services for glycoscience and screening of carbohydrate-modifying enzymes, helping to create better and more sustainable food & beverage products. The company provides services for glycoscience and offers rapid screening of carbohydrate-modifying enzymes by reducing the technology gap, enabling breweries, malthouses, dairies, and other food producers to focus on raising sustainability, and save time, and lowering their costs at the same time.
#12
Acqui-Hired · Copenhagen, Capital Region of Denmark · founded 1999 · 42 employees$30.5Mraised▾
Developer of technologies to visualize the real-time movements and interactions of proteins in living cells. The company discovers pharmaceutical compounds and drug targets through the use of cell-based imaging technologies that track redistribution events in intracellular signaling pathways.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Platforms and Tools coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics is moving in Denmark
A read on the academic research around Bioinformatics — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 593 Denmark-affiliated papers.
- University of Copenhagen183
- Aarhus University121
- Technical University of Denmark118
- Novo Nordisk Foundation65
- Copenhagen University Hospital59
- Gene2→25
- Genome5→19
- DNA sequencing2→10
- Population1→8
- Metagenomics2→8
- Gene2→8
- Metagenomics1→5
- Microbiome1→5
- DNA sequencing2→5
- microRNA1→4
- Gene2→5
Where bioinformatics is researched across Denmark
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.